Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 65 years of age
- People who scored between 3 and 9 points on a specific altitude sickness rating scale called the Lake Louise Acute Mountain Sickness Scale (2018 version)
- People whose chest X-ray shows either thickening of the lung tissue on both sides, or small spot-like areas in the lower parts of both lungs
- People who are able to give formal written consent to participate, as required by local rules
Who may not be able to join:
- People with certain serious heart conditions present from birth, such as severe underdevelopment of the left side of the heart, or heart defects that depend on a specific blood vessel (the ductus) to function
- People with life-threatening birth defects and heart failure, or a rare inherited blood condition called congenital methemoglobinemia
- People with serious bleeding conditions, including bleeding in or around the brain or in the lungs
- People whose heart pumps less than 40% of its blood out with each beat (a measure of how well the left side of the heart works), indicating significant heart weakness
- People whose fluid on the lungs is caused by a heart condition, another lung condition, a chest condition, or another illness in the body
- People who also have high altitude cerebral edema (swelling of the brain caused by altitude)
- People with a history of lung cancer, surgical removal of part or all of a lung, or a lung transplant
- People with certain types of air trapped abnormally in the chest, such as a collapsed lung, air under the skin or around the heart, or a chest drainage tube already in place
- People with a significantly low platelet count (below 50×10⁹/L), which affects the blood's ability to clot
- People who have taken certain medications for high blood pressure in the lungs — such as sildenafil, bosentan, or prostacyclins — within the past 30 days
- People who are unwilling to follow the study procedures or provide consent to participate
- People whom the treating doctor considers unsuitable for the trial for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jingxin Cao, Tibet Fokind Hospital
Phone: 15655595707
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change of Oxygen Index
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.